FDA Inspection
Hetero Drugs Ltd. - Unit 1Hetero Drugs Ltd. - Unit 1 – FDA Inspection, May 16, 2025
Record Details
This FDA Inspection record concerns Hetero Drugs Ltd. - Unit 1, with an inspection on May 16, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 728fbd7f-8fcd-4259-b230-c3f8aa5ede35
Inspection Facts
- Inspection number
- 1269555
- FDA center
- Human Drugs
Other FDA inspections of Hetero Drugs Ltd. - Unit 1
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 14, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 2, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 25, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 2, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 11, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hetero Drugs Ltd. - Unit 1
- FDA Inspection 1121294 - 2020-02-14
- FDA Inspection 1044698 - 2018-03-02
- FDA Inspection 963050 - 2016-02-25
- FDA Inspection 888747 - 2014-05-02
- FDA Inspection 700761 - 2010-11-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.